Scendea’s Post

Steady drug development growth in the China has translated into many innovative drug approvals that improve patients’ quality of life around the world. While immense opportunities as being best-in-class or first-in-class innovative products with strong potential to address unmet medical needs globally, China based biotech companies still are facing common partnership challenges in their global development journey as they attempt to seamlessly advance their assets to the next stage of development and increase their speed to market. The discussion will focus on the development landscape and ways and means to maximize the value of Biotech portfolio and how a strategic collaboration with a best-in-class CRO can help in achieving your development goals. Voices from the industries are being heard. Focusing on key challenges in competitive landscape at the investigator sites, evolving global regulation and market entry, in-depth conversation are conducted to find out how global CRO would expedite drug development and drive better value to China local clients. We’re looking forward to meeting you in Suzhou! Time: May 17 15:30 -18:00 Venue: 2F New York & London Hall, SIP Novotel, Suzhou, China

Together we are stronger. CSI Medical Research has been able to leverage on ClinChoice’s support in DIA China 2024 to showcase our Southeast Asia and ANZ (SEAANZ) capabilities. There have been quite a number of interested parties wanting to understand the feasibility and strategies of bringing their products overseas. Apart from being cost effective, relatively competitive startup timelines, access to diverse ethnic data, global renowned key opinion leaders, etc, SEAANZ region is an attractive options for Chinese customers trying to prepare for commercialization beyond the conventional US and EU market. After all, access to a market of close to 700 million population does not sound bad at all, does it? Reach out to us if you have any questions about SEAANZ and we will be happy to discuss. In parallel, if any of the investigators that would be interested to have access to any treatments or devices, we will be happy to connect you to the appropriate stakeholders too! #clinicaltrials #commercialization #Southeastasia #ANZ #improvinglives

Our main concern has always been how we can further enhance the quality of life for patients. With this guiding principle in mind, we recently concluded a highly productive Medical Affairs Summit. Over the course of three days, we had the privilege of hosting Medical Affairs Teams from Turkiye, Russia, Belarus, and Kazakhstan in Istanbul. Through fruitful discussions, mutual learning, and a thorough review of our priorities and practices, we strengthened our connections and explored innovative approaches. Moreover, we focused on the potential of data, digital solutions, and technology to advance our objectives. The diversity within our team fostered a dynamic synergy, leading to the introduction of new goals. We are excited about the opportunities that lie ahead and our commitment to making a positive impact on the lives of our patients. I would like to extend my thanks to our leaders, project team, and last but not least, the medical affairs participants who made this meeting possible. Elena Kartasheva, Carla Amigo,Andrea Pino,Omur Mangaloglu, Julia Chetverikova, MD, Mikhail Vladimirov, Oleg Navras, Ken Yong, Kershnie Rambalee, Fernando Borras, Buket Özgür, Neval Apaydın,Olga Frolova, Gonca Sönmez Uyguç, Özel Kutlu, Gulsah Dogan Alakus, Beatrice Omisakin, Song Wang,Svetlana Tenisheva, Zhuldyz Amanova, Alper Aydıncı, Gökhan Varol Takeda on LinkedIn: #takedagem #medicalaffairs #innovation #patientoutcomes

Top5️⃣Reasons You Can’t Miss #LAAM24: https://ow.ly/kyUU50SnyTX 1️⃣#Networking Opportunities: Connect with key stakeholders and influencers driving initiatives in #LatinAmerica and the #Caribbean. 2️⃣Cross-Track Synergy: This year's meeting features three comprehensive tracks—#Regulatory/Clinical, Safety and #Pharmacovigilance, and Medical Affairs and Scientific Communications (#MASC) 3️⃣Knowledge Sharing: Break down silos and explore the intersection of regulatory, #clinical, safety, #pv, and #medicalaffairs and scientific communications. 4️⃣#Global Reach, Local Impact: Dive into discussions on multi-regional cooperation, global harmonization, and best practices tailored to Latin America and the Caribbean from #real-world case studies. 5️⃣#Language Inclusivity: Enjoy seamless participation with simultaneous interpretation available in English, #Spanish and #Portuguese.

Takeda Growth Emerging Marketing (GEM) TuRC Organization recently hosted a successful Medical Affairs Summit in Türkiye. Our dedicated Multi Country Organizations TuRC (Turkey, Russia, Belarus, and Kazakhstan) team gathered to discuss our medical strategies for 2024 and to explore the significant impact of rapidly advancing technology on our business. The summit was a resounding success, featuring engaging discussions and inspiring keynote speakers who provided valuable insights into the ever-evolving landscape of our industry. We are confident that the outcomes and insights generated during this event will lead to highly productive results for the entire region. As always, we remain steadfast in our commitment to delivering innovative solutions and improving patient outcomes. #TakedaGEM #MedicalAffairs #Innovation #PatientOutcomes

📢 JTA International Investment Holding Expands Investment Portfolio in Turkey! From May 19-24, 2024, our CEO, Dr. Amir Ali Salemi, and the JTA Management team embarked on a strategic visit to Turkey, further strengthening our investment presence in the region. 🇹🇷 During the trip, the team held several key meetings with: 🔹 The Mayor of Istanbul 🔹 Movie production companies 🔹 Real estate companies 🔹 Leading business figures in the pharmaceuticals and energy sectors These discussions focused on new investment opportunities, particularly in movie production, pharmaceuticals, energy, and real estate, reinforcing our commitment to contributing to Turkey's thriving economy and expanding JTA's diverse portfolio. 🤝 With strong partnerships and new business prospects on the horizon, JTA remains dedicated to fostering innovation and growth across multiple sectors, making impactful investments in Turkey and beyond. Click here for more info: https://lnkd.in/eCncM3j5 #JTAHolding #TurkeyInvestments #BusinessOpportunities #RealEstate #Pharmaceuticals #MovieProduction #Energy #GlobalInvestment #EconomicGrowth

The latest #mpox #outbreak has highlighted gaps in #vaccineproduction in #Africa. Several major #pharma companies have tried to set up #manufacturing facilities in Africa, but have found it difficult due to a variety of reasons. How will #bigpharma continue their operations in the region? Read my take here: https://lnkd.in/gCVAb8hA

If you're traveling to Europe from North America in April for the spring cannabis conference season, why not consider a stop in The Hague for The Cannabis Summit before heading to Berlin for InternationalCBC? It couldn't be simpler, and you'll have the opportunity to experience the best of both cities and grow your business at the same time. The Cannabis Summit, tailored for industry leaders and professional service providers, is scheduled for Friday, April 12th, at the prestigious World Horti Center in The Hague. Featuring an outstanding program and a lineup of distinguished speakers, this conference is a premier B2B conference for those seeking insights from global experts in cultivation, genomics, and smart farming. Attendees will also gain valuable knowledge about the Dutch Controlled Cannabis Supply Chain Experiment. With its blend of historical elegance and modern sophistication, The Hague offers an ideal stopover en route to Berlin, inviting travelers to immerse themselves in its captivating culture before continuing their journey to ICBC which takes place between April 15th and 17th. The Hague to Berlin ======================================================= (1) Take an Intercity train trip from The Hague directly to Berlin Hauptbahnhof. This journey takes approximately 6 hours, but eliminates the need to spend time at the airport. Tickets cost about €65 on the Deutsche Bahn Intercity-Express. (2) Fly from Amsterdam Schiphol to Berlin Brandenburg. Tickets cost about €150 one-way, and the journey (including the train from The Hague to Schiphol and from Berlin Brandenburg to Berlin) takes approximately 5.5 hours. (3) If you're driving, the trip takes about 6.5 hours from The Hague to Berlin. #cannabis #B2B #Germany #Berlin #legalization #marijuana #netherlands #amsterdam #weed #cannabisnews #cannabisindustry #thehague #dutch #cultivation #coffeeshop Eoin Long Sonny Moerenhout Claudia Della Mora Sita Schubert Jillian Reddish Mariana L. Robert Hoban Atiyyah Ferouz Alexandre Gauthier Deepak Anand Mikhail Sagal Dr. Malgorzata (Gosia) Meunier

China will soon enter a market dominated so far by western so called BIG PHARMA. They streamlined their drug approval processeses. In addition, the government sponsers the modernization of the drug discovery process (learning from their poor response to COVID and using AI). Which in return triggeres more and more investments in this area. After all: China is the second largest pharma market in the world with a huge potential for growth.

Top5️⃣Reasons You Can’t Miss #LAAM24 1️⃣𝐍𝐞𝐭𝐰𝐨𝐫𝐤𝐢𝐧𝐠 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬: Connect with key stakeholders and influencers driving initiatives in Latin America and the Caribbean. Forge valuable connections that can propel your projects forward. 2️⃣𝐂𝐫𝐨𝐬𝐬-𝐓𝐫𝐚𝐜𝐤 𝐒𝐲𝐧𝐞𝐫𝐠𝐲: This year's meeting features three comprehensive tracks—Regulatory/Clinical, Safety and #Pharmacovigilance, and Medical Affairs and Scientific Communications (#MASC)—ensuring there's something for everyone in the industry. 3️⃣𝐊𝐧𝐨𝐰𝐥𝐞𝐝𝐠𝐞 𝐒𝐡𝐚𝐫𝐢𝐧𝐠: Break down silos and explore the intersection of #regulatory, #clinical, safety, pharmacovigilance, and medical affairs and #ScientificCommunications. 4️⃣𝐆𝐥𝐨𝐛𝐚𝐥 𝐑𝐞𝐚𝐜𝐡, 𝐋𝐨𝐜𝐚𝐥 𝐈𝐦𝐩𝐚𝐜𝐭: Dive into discussions on multi-regional cooperation, global #harmonization, and best practices tailored to #LatinAmerica and the Caribbean from #real-world case studies. 5️⃣𝐋𝐚𝐧𝐠𝐮𝐚𝐠𝐞 𝐈𝐧𝐜𝐥𝐮𝐬𝐢𝐯𝐢𝐭𝐲: Enjoy seamless participation with simultaneous interpretation available in #Spanish and #Portuguese, ensuring everyone can engage fully in the discussions and workshops. ➡️Don't miss this opportunity to be part of stimulating discussions, share knowledge, and foster collaboration amongst stakeholders in Latin America and the #Caribbean: https://ow.ly/ThWQ50RPnSS